J David Warren

J David Warren discloses dealings in Adaptogenics Health Corp. to SEDI. In total, 2 filings cover trades dated from 1 October 2026 to 2 October 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 7 October 2026 came the latest disclosure, an option exercise for €12k in Adaptogenics Health Corp. This summary is built from SEDI disclosures alone and does not predict where the share price will go.